By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PharmaCore, Inc. 

4180 Mendenhall Oaks Parkway
Suite 160
High Point  North Carolina  27265  U.S.A.
Phone: 336-841-5250 Fax: 336-841-5251


Since 2000, PharmaCore has performed chemistry services for pharmaceutical and biotechnology companies including: custom organic synthesis; cGMP scale-up; nonGMP and GMP API manufacture; controlled substance R&D and manufacture; chemical process research and development; and analytical services. Headquartered in High Point, NC, the 35,000 square foot facility is fully equipped with 43 bench-top hoods, 18 walk-in hoods, and eight GMP process suites. Most GMP analytical testing and GMP regulatory support are provided on-site.

PharmaCore's GMP manufacturing facility is designed with maximum versatility with process conditions of -70 to 160+°, glass and Hastelloy, computer monitoring and flexible equipment configurations. Reactors with process volumes from 2000 liters to laboratory scale are ready to supply your clinical needs.

PharmaCore's GMP analytical laboratories are equipped with the most up-to-date instrumentation, including ICH Q1A-compliant stability chambers. Our seasoned team of scientists brings a wealth of pharmaceutical industry experience to your project.

With increasing dependence of the industry on outsourcing chemistry, pharmaceutical companies and emerging drug discovery companies come to PharmaCore to augment their internal capabilities, serve as their ‘stand-alone’ chemistry team and all levels between. Route scouting, process R&D and improvements are key capabilities at PharmaCore. This leads to successful preclinical to clinical API manufacture in our state-of-the art pilot plant.

It is for these reasons that PharmaCore was recently selected by the industry to receive CMO Leadership awards in the areas of quality, reliability and innovation. Likewise, PharmsCore received its first FDA inspection and was issued no 483’s. These activities are a testament to PharmaCore’s focus on excellence.

Key Statistics

Ownership: Private

Web Site: PharmaCore, Inc.

Drug Discovery

Company News